ACE2 and COVID-19: Importantly, des-Arg bradykinin is involved locally in vessel dilation through binding to the B1 receptor, while kinetensin stimulates mast cell degranulation and vascular permeability [15], and he increased ACE2 shedding could cause dysregulation of the kallikrein–kinin system and have a possible influence on cutaneous COVID-19.